yenyap

    • yenyapyenyap
      ·05-21
      $Crown Electrokinetics Corp.(CRKN)$   $12M gross revenue LOS ANGELES, CA / ACCESSWIRE / May 21, 2024 / Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading smart glass technology company and an expert in constructing fiber optic networks, today announced that it has secured a new long haul dark fiber construction project spanning approximately 250 miles from Las Cruces, New Mexico to El Paso, Texas. Corey Boaz, President of Construction for Crown Fiber Optics stated. "We are pleased to announce today's new project with Sequoia Associates. This project represents an approximate $12M gross revenue opportunity and marks our first project as a turnkey general contractor.
      707Comment
      Report
    • yenyapyenyap
      ·05-21
      $Crown Electrokinetics Corp.(CRKN)$   Will go to the Moon 🌝 🌝 🌝 🚀 🚀 🚀 😁 😁 😁 tomorrow or post market when people read the news. Faster buy the dip now. https://finance.yahoo.com/news/crown-fiber-optics-announces-long-120000468.html
      316Comment
      Report
    • yenyapyenyap
      ·05-21
      Go to the Moon $1 -$2 very soon 
      Sorry, this post has been deleted
      53Comment
      Report
    • yenyapyenyap
      ·2022-02-12
      $Pfizer(PFE)$year 2021 sales was $80 billion and price hit 60, this year sales will be $100 billion thus its price will hit $75
      476Comment
      Report
    • yenyapyenyap
      ·2022-02-12
      $Pfizer(PFE) last year sales was $80 billion price hit to $60, this year forecast sales $100 billion or more thus the price will hit $70 to $75 with China Paxlovid 's purchase. HOLD tight 
      271Comment
      Report
    • yenyapyenyap
      ·2022-02-10
      $Pfizer(PFE)$ So many good news but Institutes just manipulate the share price, HOLD tight, they are shorting it. 
      691Comment
      Report
    • yenyapyenyap
      ·2022-02-09
      From the Q&A, Pfizer has bright prosperity, target to achieve $70 soon this year. 

      Pfizer Q4 2021 Q&A Session Transcript

      @Tiger_Earnings
      Q&A(Question-and-Answer Session)is a session after the company's prepared remarks where institutional investors and analysts ask management questions. In this dialogue you may find some valuable information that might affect the stock price in the following weeks. Now let's look at some key points from Pfizer Q4 2021 Q&A Session Transcript$Pfizer(PFE)$ Q:Hey, guys. Thanks for taking the question. Just had two. The first one, Paxlovid guidance, I know you guys are factoring in only signed agreements, but can you give us a general sense as to agreements or doses perhaps that are under discussion, and is that dependent on supply ramping? The second question, on external DV, Albert, I understand the strategy. I think the uncertainty is really the
      Pfizer Q4 2021 Q&A Session Transcript
      237Comment
      Report
    • yenyapyenyap
      ·2022-02-09
      Institutes are manipulating the share price, it should shoot up to the Moon but they short it with huge amount of shares..😂 

      Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?

      Pfizer shares dropped sharply on Tuesday after the company’s 2022 sales guidance appeared to fall sh
      Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?
      305Comment
      Report
    • yenyapyenyap
      ·2022-02-03
      It raised from 157 to 188 few days ago, ppl sell the news. 

      Qualcomm Slid Nearly 4% in Premarket Trading Though It Showed Strong Earnings and Outlook

      Qualcomm slid nearly 4% in premarket trading though it showed strong earnings and outlook. For its f
      Qualcomm Slid Nearly 4% in Premarket Trading Though It Showed Strong Earnings and Outlook
      257Comment
      Report
    • yenyapyenyap
      ·2022-01-27
      $PFE will up to $60 today or next week? 
      Sorry, this post has been deleted
      460Comment
      Report
       
       
       
       

      Most Discussed

       
       
       
       
       

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email:uservice@ttm.financial